Recent Content
-
_thumb.png)
Interim Data Provides Valuable Information that Drives Volatility in Global Markets
-
August closes out a blockbuster month for IPOs, but SPACs continue to dwindle
-
Wall Street Horizon Introduces Interim Calendar
-
Shareholder Meetings and Conferences Ramp Up Ahead of Q3 Earnings Season
-
Investing.com: 10 Companies With Off-Trend Q2 Earnings Dates And Results
-
_thumb.png)
Where are they now? 7 out of 10 companies with off-trend Q2 earnings dates performed as our data indicated
-
_thumb.png)
Geopolitical Risks in Emerging Markets Create Added Uncertainty for Multinational Companies
-
Back-to-School Boom: A Closer Look at Same Store Sales Data
-
Investing.com: Back-to-School Boom - A Closer Look At Same Store Sales Data
-
_thumb.png)
Global Firms Reported Strong Q2 Profits Despite Delta Variant Fears
WSH Incorporates Drug Approval Dates from BioMedTracker for Pharma Traders
Event date information provider Wall Street Horizon has added US Food and Drug Administration drug approval dates and related events from Informa subsidiary BioMedTracker to its Enchilada platform, to meet investor demand for market-moving information on pharmaceutical stocks.
Access full article
